# Analysis of the correlation between vaginal microbiota and high-risk human papillomavirus infection and cervical lesions

**Authors:** Yan Chen, Wei Qiu, Guolong Xiao, Rujing Zhang, Linlin Zhang

PMC · DOI: 10.1371/journal.pone.0343027 · PLOS One · 2026-02-27

## TL;DR

This study explores how changes in vaginal bacteria relate to high-risk HPV infection and cervical lesions, suggesting microbiota could help predict cervical disease risk.

## Contribution

The study introduces a predictive model using vaginal microbiota data to assess cervical lesion risk in hrHPV-positive women.

## Key findings

- Vaginal microbiota in hrHPV-positive and CIN groups differ significantly from healthy controls.
- The random forest model showed good performance in predicting cervical lesion risk based on microbiota profiles.
- Pathogenic bacteria increase and beneficial bacteria decrease during hrHPV infection.

## Abstract

The aim of this study was to evaluate changes in the vaginal microbiota and biomarkers among high-risk human papillomavirus (hrHPV)-positive women, those with hrHPV accompanied by mucositis, and patients with cervical intraepithelial neoplasia (CIN) and to establish a novel predictive model. Vaginal samples from 102 women were categorized into four groups: control group (n = 26), hrHPV-positive group (n = 22), hrHPV-positive with mucositis group (n = 26), and CIN group (n = 28). Microbiota analysis was performed using the PacBio platform with full-length 16S rDNA gene sequencing. The vaginal microbiota in the hrHPV-positive, hrHPV-positive with mucositis, and CIN groups showed significant differences compared with the healthy control group. The microbial richness in the hrHPV-positive group was significantly different from both the CIN group and healthy controls. Compared with the control group, the hrHPV-positive group exhibited significantly increased relative abundances of Bifidobacterium, Escherichia-Shigella, Hoylesella and nominally increased abundances of Gardnerella, Prevotella, along with a significant decrease in Lactobacillus. No statistically significant differences were retained between the hrHPV-positive group and the hrHPV-positive with mucositis group after FDR correction for the top 10 genera. Compared with the hrHPV-positive with mucositis group, the CIN group demonstrated significantly reduced levels of Pseudomonas, nominally decreased levels of Bifidobacterium and Faecalibacterium, whereas Glutamicibacter and Sporosarcina were nominally enriched. A random forest model was constructed to predict risk across groups and demonstrated good predictive performance, suggesting that vaginal microbiota may serve as valuable indicators for predicting cervical lesion risk. During hrHPV infection, significant alterations occur in the vaginal microecology, primarily characterized by an increase in pathogenic bacteria and a reduction in beneficial bacterial populations.

## Linked entities

- **Diseases:** cervical intraepithelial neoplasia (MONDO:0022394), mucositis (MONDO:0020579)
- **Species:** Bifidobacterium (taxon 1678), Hoylesella (taxon 2974257), Gardnerella (taxon 2701), Prevotella (taxon 838), Lactobacillus (taxon 1578), Pseudomonas (taxon 286), Faecalibacterium (taxon 216851), Glutamicibacter (taxon 1742989), Sporosarcina (taxon 1569)

## Full-text entities

- **Genes:** AP2B1 (adaptor related protein complex 2 subunit beta 1) [NCBI Gene 163] {aka ADTB2, AP105B, AP2-BETA, CLAPB1}
- **Diseases:** precancerous lesions (MESH:D011230), abortions (MESH:D000026), Infection (MESH:D007239), gynecological malignancies (MESH:D005833), mucositis (MESH:D052016), Breast Cancer (MESH:D001943), ASC-H (MESH:D065309), infectious diseases (MESH:D003141), tract (MESH:D014570), immune dysregulation (OMIM:614878), HSIL (MESH:D000081483), Cervical cancer (MESH:D002583), BV (MESH:D016585), chronic mucosal inflammation (MESH:D007249), CIN (MESH:D002578), cancer (MESH:D009369), carcinoma in situ (MESH:D002278), vaginal dysbiosis (MESH:D064806), implantation failure (MESH:D051437), carcinogenesis (MESH:D063646), glandular abnormalities (MESH:D007244), cervical epithelial dysplasia (MESH:C567703), Cervical (MESH:D002575), SCC (MESH:D002294), HPV (MESH:D030361)
- **Chemicals:** hydrogen peroxide (MESH:D006861), TAE (-), putrescine (MESH:D011700), CTAB (MESH:D000077286), butyrate (MESH:D002087), agarose (MESH:D012685), lactic acid (MESH:D019344), water (MESH:D014867)
- **Species:** Fusobacteriota (phylum) [taxon 32066], Streptococcus (genus) [taxon 1301], Homo sapiens (human, species) [taxon 9606], Gardnerella (genus) [taxon 2701], Bifidobacterium (genus) [taxon 1678], Alphapapillomavirus (genus) [taxon 333750], Sneathia (genus) [taxon 168808], Thermodesulfobacteriota (phylum) [taxon 200940], Glutamicibacter (genus) [taxon 1742989], Pseudomonas (RNA similarity group I, genus) [taxon 286], Candida albicans (species) [taxon 5476], Faecalibacterium (genus) [taxon 216851], Atopobium (genus) [taxon 1380], Chlamydiota (phylum) [taxon 204428], Lactobacillus (genus) [taxon 1578], Human papillomavirus (species) [taxon 10566], Prevotella (genus) [taxon 838], Gardnerella vaginalis (species) [taxon 2702], Megasphaera (genus) [taxon 906]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12948077/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12948077/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12948077/full.md

---
Source: https://tomesphere.com/paper/PMC12948077